A lapsed streaming deal and the ongoing Paramount-Skydance merger review have left viewers outside the U.S. scrambling for ...

The takeover of Accuidity Capital Management boosts Forge Global's AUM by 20%. Read why I've retained a Buy rating for FRGE ...

Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has ...

The antibody, ISB 2001, is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) ...

Oryx invests in the minerals value chain, targeting critical and strategic minerals assets in favorable jurisdictions ...

TAC Security, a global leader in cybersecurity solutions and listed as TAC InfoSec Limited (NSE Emerge: INE0SOY01013), is ...

Global demand for culturally rich audio is turning traditional Scottish music into a sought-after asset in film, advertising, and digital storytelling ...

Businesses say the rising music licensing costs have become overwhelming, and some question whether it’s even worth playing ...

Today's rally followed Glenmark's Thursday announcement that its innovation arm, Ichnos Glenmark Innovation (IGI), has ...

Sequans is gaining traction in IoT with strong sales growth, a solid pipeline, and strategic upside from licensing and ...

Lupin has signed a $50 million licensing deal with Zentiva for the global commercialization of its biosimilar Certolizumab Pegol, targeting markets like the US, Canada, and Europe.